U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06815549) titled 'An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"' on Feb. 03.
Brief Summary: This study is designed to evaluate the safety, clinical efficacy and antibacterial activity of the drug Fluorothiazinone, 300 mg tablets, (Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation) in the mode of antibacterial monotherapy with the participation of adult patients with chronic bacterial cystitis.
The main objectives of this study are:
1. To evaluate the safety of the use of the ...